GREENFIELD PHARMACEUTICALS LIMITED - Profile & Financials

Accounts Submitted 18 Aug 2025

Confirmation Statement Submitted 26 Aug 2025

Net assets £2.11M £0.00 2023 year on year

Total assets £2.11M £0.00 2023 year on year

Total Liabilities £0.00

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Eli Lilly And Company Limited, Lilly House Basingview Basingstoke Hampshire RG21 4FA United Kingdom

Credit Report

Discover GREENFIELD PHARMACEUTICALS LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2023

Type Total Exemption Full

Next accounts 31 December 2024

Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2021–2023)

Cash in Bank

N/A

Net Assets

£2.11M

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

	2023 Dec Year End	2022 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

2 active 33 resigned

Show resigned officers

						Status
Christopher J Stokes	Director	American	United Kingdom	47	3 Jul 2024	Active
Kristina Mignon Wright	Director	American	England	47	8 Aug 2025	Active

Shareholders

Shareholders (1)


Eli Lilly And Company Ltd	100.0%	600,000	Ordinary	28 Aug 2015

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Eli Lilly And Company Limited

United Kingdom

Active

Notified 14 Aug 2016

Nature of Control

Ownership Of Shares 75 To 100 Percent
Voting Rights 75 To 100 Percent
Right To Appoint And Remove Directors
Significant Influence Or Control As Firm

See All Controllers

Group Structure

ELI LILLY AND COMPANY LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors as firm, significant influence or control as firm

ELI LILLY GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors as firm, significant influence or control as firm

ELI LILLY AND COMPANY united states of america

GREENFIELD PHARMACEUTICALS LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
3 Sept 2025	Officers	Change to director Kristina Mignon Wright on 2025-09-01	View(2 pages)
26 Aug 2025	Confirmation Statement	Confirmation statement made on 2025-08-14 with no updates	View(3 pages)
18 Aug 2025	Accounts	Annual accounts made up to 2024-12-31	View(3 pages)
14 Aug 2025	Officers	Appointment of Kristina Mignon Wright as director on 2025-08-08	View(2 pages)
14 Aug 2025	Officers	Termination of Yuya Nonaka as director on 2025-08-08	View(1 page)